Cargando…
Discovery of GPCR ligands for probing signal transduction pathways
G protein-coupled receptors (GPCRs) are seven integral transmembrane proteins that are the primary targets of almost 30% of approved drugs and continue to represent a major focus of pharmaceutical research. All of GPCR targeted medicines were discovered by classical medicinal chemistry approaches. A...
Autores principales: | Brogi, Simone, Tafi, Andrea, Désaubry, Laurent, Nebigil, Canan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246677/ https://www.ncbi.nlm.nih.gov/pubmed/25506327 http://dx.doi.org/10.3389/fphar.2014.00255 |
Ejemplares similares
-
Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1
por: Gasser, Adeline, et al.
Publicado: (2015) -
Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018) -
Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
por: Thuaud, Frédéric, et al.
Publicado: (2013) -
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020) -
Subcellular location defines GPCR signal transduction
por: Radoux-Mergault, Arthur, et al.
Publicado: (2023)